홈 › 흑색종 › 텍사스 › San Antonio
TX San Antonio의 흑색종 임상 시험
흑색종 관련 연구 15개가 San Antonio 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
피험자 모집 중1/2상
- START South Texas Accelerated Research Therapeutics, San Antonio
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- The University of Texas Health Science Center at San Antonio, San Antonio
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
피험자 모집 중1/2상
- South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Audie L Murphy VA Hospital, San Antonio
Project: Every Child for Younger Patients With Cancer
피험자 모집 중관찰 연구
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- UT Health Mays Cancer Center, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
피험자 모집 중1상
- START San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Next Oncology, San Antonio
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
피험자 모집 중1/2상
- Next Oncology, San Antonio
- The Start Center for Cancer Care, San Antonio
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
피험자 모집 중1/2상
- Research Site, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
피험자 모집 중1/2상
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
피험자 모집 중
- University of Texas Health Science Center at San Antonio, San Antonio
다른 도시의 흑색종 시험
- Houston, TX연구 59개
- New York City, NY연구 38개
- Los Angeles, CA연구 34개
- Nashville, TN연구 32개
- Pittsburgh, PA연구 31개
- Boston, MA연구 25개
- Philadelphia, PA연구 23개
- San Francisco, CA연구 22개
- Atlanta, GA연구 21개
- Columbus, OH연구 21개
- Salt Lake City, UT연구 21개
- Durham, NC연구 21개
San Antonio의 다른 연구
- 비소세포폐암연구 59개
- 대장직장암연구 46개
- 유방암연구 46개
- 전이성 암연구 44개
- 암 (전체)연구 41개
- 비만연구 39개
- 제2형 당뇨병연구 37개
- 과체중연구 33개
- 췌장암연구 31개
- 난소암연구 31개
- 전립선암연구 28개
- 자궁내막암연구 27개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.